Related Experiment Video
Updated: Aug 8, 2026
07:39
Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
[Study on fetal SRY gene in maternal plasma using nested polymerase chain reaction]
Ping Hong1, Pei-yuan Zhu, Yu-feng Huang
1Department of Micobiology & Immunology, Nanjing Medical University, Jiangsu, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|May 11, 2006
Summary
A novel nested polymerase chain reaction (PCR) technique effectively identifies fetal SRY gene from cell-free fetal DNA in maternal plasma, enabling non-invasive sex determination.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Context:
- Prenatal diagnosis traditionally involves invasive procedures.
- Cell-free fetal DNA (cffDNA) in maternal plasma offers a non-invasive source for genetic analysis.
- Sex determination is crucial for managing sex-linked inheritant diseases.
Purpose:
- To develop and validate a nested polymerase chain reaction (PCR) method for detecting the fetal SRY gene in maternal plasma.
- To assess the efficacy of phenol/chloroform DNA extraction from plasma for this purpose.
- To evaluate the accuracy and sensitivity of the nested PCR technique for non-invasive fetal sex determination.
Summary:
- A nested PCR technique was developed to amplify the SRY gene from cell-free fetal DNA extracted from maternal plasma using the phenol/chloroform method.
- The assay demonstrated high accuracy (93.3%) and sensitivity (88.2%), successfully identifying the SRY gene in 15 out of 17 male fetuses.
- No positive SRY gene detection was observed in samples from 13 women carrying female fetuses.
Impact:
- This nested PCR approach provides a simple, convenient, and low-cost method for early non-invasive prenatal diagnosis.
- It facilitates the management of pregnancies at risk for sex-linked inheritant diseases.
- The study validates phenol/chloroform extraction as an effective method for isolating cffDNA for diagnostic applications.
